13.11.2013 06:00:00
|
DEINOVE Receives Significant Funding for a Major Innovative Project in Plant Chemistry from the French Government
Regulatory News :
DEINOVE (Paris:ALDEI) (Alternext Paris: ALDEI), a technological company that designs, develops and markets a new generation of industrial processes based on Deinococci bacteria, has announced today that their plant chemistry development programme has been chosen by ADEME and the General Investment Commission. They will receive significant funding – nearly 6 million euros – from the government that clearly wishes to support this sector.
"We are delighted to support this internationally-ambitious French industrial project. DEINOVE was founded in France and works on developing solutions for tomorrow with breakthrough technologies … which are included as part of French innovations that need to be heavily supported in order to join the world-wide race”, emphasized Arnaud Montebourg, Minister of Industrial Renewal.
"This is one of the highest levels of financial backing ever granted in plant chemistry from the French government. Our country has clearly placed biotechnologies at the heart of its industrial innovation programme and DEINOVE was identified in Anne Lauvergeon’s ‘Innovation 2030’ Report as a cutting-edge company in the field of plant chemistry, which is considered a strategic sector for the inevitable shift in energy sources; away from fossil fuels that pollute and are running out”, commented Emmanuel Petiot, CEO of DEINOVE.
"We are very proud to have been chosen for this project. This support is combined with an ambitious investment programme which aims to help DEINOVE emerge as a major player in French biotechnologies within the framework of their global ambition,” said Philippe Pouletty, Chairman and co-founder of DEINOVE.
On a global scale, green chemistry already constitutes a market of 135 billion dollars (100 billion euros) and a sharp increase is expected within the next few years. Europe is the world’s 2nd largest agricultural producer1 with a large biomass reserve at its disposal, and has several leading groups in the fields of chemistry and agribusiness. France, the top agricultural producer in Europe, has the means to reinforce its leading position by the quality of its research and its technological innovation.
The DEINOCHEM programme and isoprenoids
The
DEINOCHEM programme aims to produce a new generation of chemical
compounds which can be substituted for those that are traditionally
petro-sourced. Using Deinococci bacteria, these new chemical
compounds are made from non-food biomass such as wheat straw, corn
stover and cobs, energy crops, and industrial and urban waste. The
project initially focused on identifying the most appropriate Deinococcus
strains to produce compounds of interest for its industrial partners and
to develop the DEINOVE technological platform. An isoprenoid project was
then launched in 2010 and approved by the IAR2 cluster in
2011. This project, which deals with products such as isoprene,
carotenoids, linalool, geraniol and myrcene, is the one currently being
supported by the government. Today, these chemical intermediates
originate from the petrochemical industry, and are used in a variety of
sectors such as specialty chemicals, fragrances, animal feed, cosmetics,
pharmaceuticals, and so on. DEINOVE’s objective for the next few years
is to offer high-performance and economical bio-production processes
originating from biomass. These new processes will be based on the
exploitation of Deinococcus bacteria, which is ideal for these
types of developments: their natural expression of certain isoprenoids,
their resistance to isoprenoid toxicity, and eventually their
demonstrated capacity to render isoprenoids "hyperproducers” of a
specific product of interest.
An "Investisssement d’Avenir” Financing
Within
the framework of the "démonstrateur et plateformes technologiques en
énergies renouvelables et décarbonées et chimie verte,” an
"Investissement d’Avenir” Programme, the French Government is supporting
DEINOVE in the implementation of a research programme. The programme is
intended to develop the production of at least 2 isoprenoid compounds
derived from biomass within three and a half years. ADEME and the
General Investment Commission which brings together the relevant
ministers (Ministry of Industrial Renewal, Ministry of Higher Education
and Scientific Research, Ministry of Ecology, Energy and Sustainable
Development, Ministry of Agriculture, Agrifood and Forests) will offer
financial support in the form of repayable advances. A formal agreement
has been given by Prime Minister Jean-Marc Ayrault, and DEINOVE is
currently negotiating the final details of the project’s implementation
with ADEME.
New premises at Montpellier
In order
to boost and reinforce DEINOVE’s growth, the company moved into a new
facility at Cap Sigma in October 2013. Cap sigma is a part of the
Biopôle Euromédecine, managed by the Agglomération de Montpellier
(Montpellier Conurbation). The city offers particularly dynamic research
in the biotech field. The new offices are close to the university
campuses, and major research institutes such as CNRS (Centre national
de la recherche scientifique – French National Centre for Scientific
Research), INRA (Institut national de la recherche agronomique
– French National Institute for Agricultural Research) and CIRAD (Centre
de coopération internationale en recherche agronomique pour le
développement – French Agricultural Research Centre for International
Development), and their laboratories.
DEINOVE now occupies a 1,000m2 facility fully equipped and tailor-built by the Agglomération de Montpellier in order to cater to their specific needs: a clean room, which houses cutting-edge robotic equipment, an IT platform for gene assembly automation and the development of strains, a fermentation laboratory going from a small multi-parallel fermenter to a 20-litre fermenter, cutting-edge analytical equipment enabling molecules to be produced and a large number of metabolites to be characterised and quantified, as well as the equipment necessary for the characterisation of plant biomass components.
ABOUT DEINOVE
DEINOVE
(Alternext Paris: ALDEI) is ushering in a new era of green chemistry
order by designing and developing new standards of production based on
bacteria of untapped potential: the Deinococci. Taking advantage
of the bacteria’s unique genetic properties and unusual robustness,
DEINOVE optimizes natural fermentation and metabolic capabilities of
these bacterial "micro-factories" to produce high value added products
from non-food biomass. The Company’s primary markets are 2nd generation
biofuels (DEINOL) and chemical intermediates (DEINOCHEM). Listed on
Alternext since April 2010, DEINOVE was founded by Philippe Pouletty MD,
General Partner of TRUFFLE CAPITAL, and Professor Miroslav Radman, of
the Faculty of Medicine of the University René Descartes. The company
employs over 40 people in its new offices and laboratories located at
the Biopôle Euromédecine, in Montpellier.
More information at www.deinove.com
1 Source FAO (United Nations Food and Agriculture Organization)
2 Industries et Agro-Ressources (Industries and Agro-Resources) cluster
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DEINOVE SAmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu DEINOVE SAmehr Analysen
Aktien in diesem Artikel
DEINOVE SA | 0,00 | -99,00% |